RankingsPricing
  1. US-listed companies
  2. Edwards Lifesciences Corp
  3. Raw

Edwards Lifesciences CorpEW

Market cap
$49.9B
P/E ratio
SummaryFinancials
Back to summarized table
Dec 31,
2010		Dec 31,
2011		Dec 31,
2012		Dec 31,
2013		Dec 31,
2014		Dec 31,
2015		Dec 31,
2016		Dec 31,
2017		Dec 31,
2018		Dec 31,
2019		Dec 31,
2020		Dec 31,
2021		Dec 31,
2022		Dec 31,
2023		Dec 31,
2024
Cash and cash equivalents3961713114206547189308187141,1791,1838637691,1443,045
Short-Term Investments----785506341519242338219604446501931
Accounts Receivable, after Allowance for Credit Loss, Current277284321303288315366422457544515582643775609
Other receivables--------------118
Inventory, Net2042612813092973403975556076418027278761,1681,087
Prepaid expenses353542474945466154597585110147121
Other current assets4357577212294112117132168208237196239348
Current assets of discontinued operations (Note 5)--------------27
Total current assets1,0331,1691,2921,7262,2952,0482,2402,5322,2872,9843,0913,1813,0964,0366,285
Long-Term Investments252221222413805325675065868021,8341,239584308
Property, Plant and Equipment, Net2703043734224434835806808681,0601,3951,5471,6331,7491,686
Operating Lease, Right-of-Use Asset---------809492929498
Goodwill3153503853853766286261,1271,1121,1681,1731,1681,1641,2541,777
Other intangible assets, net (Note 11)-676757232052054683433373313242854281,177
Deferred income taxes-------214174172231247484755992
Other assets132526354913112310934102120111299464722
Non-current assets of discontinued operations (Note 5)--------------11
Total assets1,7671,9812,2222,7253,5244,0594,5105,6965,3246,4887,2378,5038,2939,36313,055
Accounts payable48857548586497117134180197205202201197
Accrued and other liabilities (Note 6)-----------8027959691,282
Operating Lease, Liability, Current---------262726262523
Current liabilities of discontinued operations (Note 5)--------------2
Total current liabilities3383353473464344765331,4038779028941,0321,0221,1951,505
Long-term debt (Note 12)---593598600822438594594595596596597598
Contingent consideration liabilities (Note 13)-------1931791731866226-15
Taxes Payable-------394259237215190143811
Operating lease liabilities (Note 7)---------597369707379
Uncertain tax positions (Note 19)---126195195230165125172214259268339385
Litigation settlement accrual (Note 3)----------2331911439453
Other liabilities121157206100106285306147150203252267218264358
Total liabilities-----------2,6672,4862,6442,992
Preferred Stock, Value, Issued---------------
Common Stock, Value, Issued117120124126129239243212215218636642646651655
Additional paid-in capital-3014896718789471,1681,1671,3841,6231,4381,7001,9692,2742,613
Retained earnings1,1241,3611,6542,0462,8423,3373,9061,9622,6953,7424,5656,0687,5908,99213,167
Accumulated other comprehensive loss (Note 17)-42-37-38-28-101-183-198-133-138-156-161-158-255-243-244
Treasury stock, at cost, 66.2 and 49.4 shares, respectively------------4,1445,0256,192
Total Edwards Lifesciences Corporation stockholders' equity1,3081,3381,4791,5592,1912,5032,6192,9563,1404,1484,5745,8365,8076,71910,063
Noncontrolling interest-------------6965
Total stockholders' equity1,308------------6,71910,063
Total liabilities and equity1,7671,9812,2222,7253,5244,0594,5105,6965,3246,4887,2378,5038,2939,36313,055